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Abstract
Introduction—Records-based autism spectrum disorder surveillance developed at the Centers 
for Disease Control and Prevention has been extended to younger cohorts, although the utility of 
additional record sources has not been examined. We therefore conducted a pilot project to 
describe whether Centers for Disease Control and Prevention surveillance could identify younger 
children with an autism spectrum disorder evaluated as part of an ongoing screening study at 
Georgia State University.
Methods—In all, 31 families of children who screened positive for autism spectrum disorder and 
received a clinical evaluation at Georgia State University agreed to participate in the project. Of 
these, 10 children lived inside the surveillance area and had records abstracted and reviewed for 
this project. Centers for Disease Control and Prevention surveillance results (i.e. autism spectrum 
disorder or non-autism spectrum disorder) were compared with Georgia State University 
evaluation results (i.e. autism spectrum disorder or non-autism spectrum disorder).
Results—In all, 4 of the 10 children were diagnosed with an autism spectrum disorder after the 
Georgia State University evaluation. None of the 4 children with an autism spectrum disorder 
were identified by current Centers for Disease Control and Prevention surveillance methods but all 
4 children were identified by Centers for Disease Control and Prevention surveillance methods 
when additional record sources were included (i.e. records from the statewide early intervention 
program and Georgia State University evaluation).
Conclusion—These findings suggest that partnering with early intervention programs and 
encouraging early autism spectrum disorder screening might improve autism spectrum disorder 
surveillance among young children.
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Introduction
Autism spectrum disorders (ASDs) are developmental disabilities that affect social, 
communication, and behavioral development and include the diagnoses of autistic disorder, 
pervasive developmental disorder–not otherwise specified (PDD-NOS), and Asperger 
disorder (American Psychiatric Association, 1994). The Centers for Disease Control and 
Prevention (CDC) has estimated that about 1 in 88 children currently have an ASD, which is 
higher than prevalence estimates previously reported (Autism and Developmental 
Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, 2012). 
CDC’s ASD prevalence estimates are used to describe the population of children with an 
ASD, identify changes in ASD prevalence over time, and provide suggestions about possible 
causes or risk factors for ASDs. CDC derives ASD prevalence estimates via a record–review 
methodology that involves the abstraction and review of education and health records of 8-
year-old children at select screening, evaluation, and diagnostic clinics and schools during a 
given surveillance year. This record–review methodology is not likely to overestimate the 
prevalence of ASDs, but is likely to miss some children with an ASD in the general 
population (Nonkin-Avchen et al., 2011).
The CDC’s ASD record–review surveillance methodology has recently been extended to 
younger cohorts at some surveillance sites. Initial analyses have suggested the estimated 
prevalence of ASDs among 4-year-olds to be about 8.0 per 1000 children, which is 
comparable with the estimated prevalence of ASDs among 8-year-olds (Nicholas et al., 
2009). However, this methodology has not been tested with direct access to records from 
statewide early intervention programs (rather than indirect access through other education 
and health records utilized for 8-year-old surveillance). Direct access to early intervention 
records might be an invaluable tool for early ASD surveillance because states are required to 
provide free intervention services for children 0–36 months of age, who meet eligibility 
criteria. Furthermore, this methodology has not been compared with that of a direct-
screening approach used to identify younger children with ASDs. Thus, the goal of this pilot 
project was to describe whether the CDC record–review methodology could identify 
children younger than 4 years with an ASD, among a small sample of children evaluated as 
part of an ongoing screening study at Georgia State University (GSU). A second goal was to 
describe how well the CDC record–review approach compared with the GSU direct-
screening approach before and after the screening result was made available in surveillance 
records.
Methods
Children were identified from an ongoing prospective screening study at GSU. Families of 
children enrolled in the GSU study completed the Modified Checklist for Autism in 
Toddlers (M-CHAT; Robins et al. 1999b, 2001) during a routine 18-month or 24-month 
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well-child visit. The M-CHAT is a short parent-report checklist designed to detect risk of 
ASDs among children 16–30 months of age when administered during general pediatric 
visits. Families of children who screened positive for an ASD on the M-CHAT were 
administered the M-CHAT Follow-Up Interview (Robins et al., 1999a), which is a 
structured interview designed to clarify parents’ responses and elicit examples of at-risk 
behaviors. Children who continued to screen positive after the Follow-Up Interview were 
invited for a free diagnostic evaluation.
Diagnostic evaluations were completed at the GSU clinic. The Mullen Scales of Early 
Learning (Mullen, 1995) was administered to assess intellectual functioning and the 
Vineland Adaptive Behavior Scales, Second Edition (Sparrow et al., 2005) was administered 
to assess daily living skills. The Autism Diagnostic Interview–Revised (ADI-R; Lord et al., 
1994), Autism Diagnostic Observation Schedule (ADOS; Lord et al., 1999), and Childhood 
Autism Rating Scale (Schopler et al., 1988) were administered to assess autism-specific 
symptoms and behaviors. Final diagnosis was made by a licensed clinical psychologist, 
using clinical judgment and integrating all data obtained during the evaluation.
Contact and enrollment
There were three ways to enroll families in this project:
1. Families who previously completed a diagnostic evaluation as part of the GSU 
screening study were contacted by letter or telephone call, or both, within 12 
months of the GSU evaluation. The current project was introduced and families 
were asked whether they would like to participate.
2. Newly enrolled families were introduced to this project at GSU during their initial 
diagnostic evaluation.
3. Newly enrolled families were introduced to this project at GSU during one of a 
number of follow-up sessions in the GSU clinic.
In all, 58 families were invited to be in the project. Of these 58 families, 31 agreed to 
participate; 17 expressed interest, but never completed the consent and release forms that 
enrolled them in the study; and 10 declined participation. Only families who lived inside the 
CDC surveillance catchment area (i.e. the five central counties of metropolitan Atlanta) and 
had records that could be located at existing partner data sources or the statewide early 
intervention program were enrolled in this project. We chose to focus on existing partner 
sources and the statewide early intervention program because these data sources are more 
feasible to access for population-based surveillance than other data sources, such as 
individual pediatric or therapy offices. Existing partner data sources were sources that, at the 
time, were partnering with the CDC ASD surveillance program (i.e. facilities that commonly 
evaluate and diagnose children with an ASD, such as local hospitals and autism diagnostic 
centers).
The 31 families who agreed to participate were placed in one of the following three 
categories after enrollment: (a) the family lived outside the surveillance catchment area, so 
records were not abstracted or reviewed (n = 5); (b) the family lived inside the surveillance 
catchment area, but did not have records that could be located at any partner data sources or 
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with the statewide early intervention program, so records were not abstracted or reviewed (n 
= 16); and (c) the family lived inside the surveillance catchment area and had records 
located at partner data sources or with the statewide early intervention program, so records 
were abstracted and reviewed (n = 10).
Procedures
CDC staff began record abstraction for children who lived inside the surveillance catchment 
area and had records located at partner data sources or with the statewide early intervention 
program (n = 10) after the GSU diagnostic evaluation was completed and consent for this 
project was obtained. Abstraction involved screening health and school records for specific 
ASD behaviors that relate to social criteria outlined in the Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) (American Psychiatric 
Association, 2000; such as limited interest in other children) and collecting verbatim 
behavioral descriptions, diagnostic summaries, and developmental assessment results from 
records that contained an ASD behavioral trigger. Information collected from records was 
then sent to a CDC clinician who applied a standardized coding scheme based on the DSM-
IV-TR to determine surveillance case status, grouped into ASD or non-ASD.
CDC clinician reviewers were professionals with advanced degrees and specialized training 
and experience in ASD assessment and diagnosis (e.g. developmental psychologists). These 
reviewers applied a standardized coding scheme based on the DSM-IV-TR to determine 
surveillance case status but did not evaluate or diagnose any child. All clinician reviewers 
had achieved and maintained acceptable reliability standards for coding ASD surveillance 
records. It is important to note that to meet ASD surveillance criteria, a child must have 
sufficient behavioral descriptors noted in surveillance records or a preexisting ASD clinical 
diagnosis or autism eligibility at a public school devoid of conflicting information contained 
in surveillance records. Therefore, if a documented clinical ASD diagnosis is present, it will 
be considered when determining surveillance case status, but it is not necessary to have this 
clinical diagnosis to meet ASD surveillance criteria. Further details of the surveillance 
methods are outlined elsewhere (Nonkin-Avchen et al., 2011; Van Naarden Braun et al., 
2002; Yeargin-Allsopp et al., 2003).
Results
The focus of this project was to describe children who were and were not identified by CDC 
ASD surveillance rather than report sensitivity and specificity due to the small sample size 
(Table 1). Of the 10 children who received a diagnostic evaluation at GSU and had 
educational and health records reviewed by CDC, all 10 children were males and 8 children 
were White (the other 2 children were Asian). The mean age at the time of GSU evaluation 
was 26.3 months (SD = 6.33 months; range = 20–42 months); education and health records 
were abstracted and reviewed from the earliest date available to 12 months after the GSU 
evaluation. On the basis of the GSU evaluation, 4 children were diagnosed with an ASD and 
6 children were diagnosed with not having an ASD. When only current surveillance partner 
records were reviewed, none of the children with an ASD were identified by record–review 
surveillance. When the statewide early intervention records were added to current 
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surveillance partner records, and only records prior to the GSU evaluation were reviewed, 2 
of the 4 children with ASDs were classified correctly as having an ASD based on record–
review surveillance. When record–review was extended to include the time period following 
the GSU evaluation, all 4 children with an ASD were classified correctly as having an ASD 
based on record–review surveillance. All the 6 children who did not have an ASD were 
classified correctly as not having an ASD based on record–review surveillance in each of the 
aforementioned scenarios. See Table 1 for a summary of results.
Of the 16 children who did not have records at partner sources or with the statewide early 
intervention program (and, therefore, did not have records abstracted and reviewed), 5 were 
diagnosed with an ASD by GSU. The health-care providers who evaluated these children 
were developmental psychologists, developmental pediatricians, and occupational therapists 
who commonly evaluate and treat young children with an ASD in Atlanta, Georgia (but who 
at the time of this study were not included as partners with CDC ASD surveillance for 8-
year-old children).
Discussion
Our results found that none of the 4 children diagnosed with an ASD who were screened at 
16–30 months of age by GSU were identified by CDC record–review methodology until 
records from the statewide early intervention program and GSU evaluation were added (at 
which time all 4 children were identified by CDC record–review surveillance). These results 
suggested at least three important considerations for surveillance protocols for younger 
children. First, ASD surveillance for children 30 months of age or older might be more 
feasible than ASD surveillance for younger children because many younger children might 
not have early intervention or other clinical evaluation records available for abstraction and 
review. The source of most toddler health information is the pediatrician, which limits the 
feasibility of surveillance for younger cohorts because pediatric screening and evaluation 
results are not recorded in a centralized database and it would be impossible to visit every 
pediatric office for surveillance of 4-year-olds to 8-year-olds. Entering developmental 
screening and evaluation results into a centralized database, such as that used to record 
neonatal metabolic and genetic screening, would be useful for ASD surveillance and might 
encourage referrals for additional developmental testing and intervention.
Second, the addition of the statewide early intervention records improved surveillance 
classification among those in our sample. Therefore, early ASD surveillance programs 
should consider partnering with statewide early intervention programs, so that more accurate 
prevalence estimates can be derived among younger cohorts. Early ASD surveillance 
programs should also consider partnering with additional health-care providers who 
commonly evaluate younger children at risk of an ASD, in addition to 8-year-old children at 
risk of an ASD, such as developmental psychologists, developmental pediatricians, and 
occupational therapists who work with children younger than 4 years of age. Particular 
attention should be given to methods that navigate access to these health records for public 
health surveillance.
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Third, because record–review classification was low before the GSU evaluation, but 
improved after results of the diagnostic evaluation were added to surveillance records, early 
ASD screening and follow-up evaluation should be encouraged to maximize the number of 
children with an ASD identified for both clinical and surveillance purposes.
The primary limitation of our pilot project was the small sample recruited and described. 
Yet, we believe that the implications and lessons gleaned from our findings are valuable 
considerations for ASD surveillance protocols that apply to younger children. The 
importance of developing accurate yet feasible surveillance protocols cannot be 
underestimated. ASD surveillance results are often used to make policy decisions and 
determine research priorities. Results from this pilot project suggested that record–review 
surveillance with appropriate record sources may be a feasible way of determining ASD 
prevalence among younger cohorts. However, results also indicated that surveillance in the 
absence of screening and follow-up evaluation or other early detection methods might have 
underestimated the prevalence of ASDs among toddlers (and that use of early ASD 
surveillance to determine peak ASD prevalence is still premature). Additional analyses on 
larger, population-based samples are needed to verify and expand upon these preliminary 
findings.
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Table 1
Record–review surveillance identification of children with an ASD.
ASD status based on diagnostic evaluation at Georgia State University
ASD (n = 4) Non-ASD (n = 6)












ASD: autism spectrum disorder.
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